Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 1, 2013, Pages

  Beneri, Christy A ^a   Zeldow, B ^b   Nachman, S ^a   Van Der Linde, M ^c   Pillay, E ^d   Dittmer, S ^e   Kim, S ^b   Jean Philippe, P ^f   Coetzee, J ^c   Bobat, R ^d   Hawkins, E ^g   Violari, A ^e  

^a STONY BROOK UNIVERSITY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^g SOCIAL AND SCIENTIFIC SYSTEMS INC   (United States)

Author keywords

Children; Retention; Tuberculosis

Indexed keywords

ISONIAZID; PLACEBO;

AGE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; FAMILY SIZE; FEMALE; FOLLOW UP; HOUSEHOLD; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MEDICAL HISTORY; MOTHER; PRIORITY JOURNAL; RISK FACTOR; SOUTH AFRICA; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INFANT; ISONIAZID; MALE; PATIENT COMPLIANCE; RISK FACTORS; SOUTH AFRICA; TUBERCULOSIS;

EID: 84871190745     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.12.0282     Document Type: Article

References (13)

1. World Health Organization. WHO tuberculosis global facts. Fact sheet 2010/2011. Geneva, Switzerland: WHO, 2010.
2. Marais B J, Gie R P, Schaaf H S, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8: 392-402. (Pubitemid 38624845)
3. Hesseling A C, Cotton M F, Jennings T, et al. High incidence of tuberculosis among HIV-infected infants: evidence from a South African population-based study highlights the need for improved tuberculosis control strategies. Clin Infect Dis 2009; 48: 108-114.
4. Madhi S A, Peterson K, Madhi A, Khoosal M, Klugman K P. Increased disease burden and antibiotic resistance causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus type 1-infected children. Clin Infect Dis 2000; 31: 170-176. (Pubitemid 32268959)
5. Madhi S, Nachman S, Violari A, et al. Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children. N Engl J Med 2011; 365: 21-31.
6. Sanne I, Orrell C, Fox M P, et al. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomized non-inferiority trial. Lancet 2010; 376: 33-40.
7. Rageuend M, Isaakidis P, Zachariah R, et al. Excellent outcomes among HIV+ children on ART, but unacceptably high pre-ART mortality and losses to follow-up: a cohort study from Cambodia. BMC Pediatrics 2009; 9: 54.
8. Miller C M, Ketlhapile M, Rybasack-Smith H, Rosen S. Why are antiretroviral treatment patients lost to follow-up? Trop Med Int Health 2010; 15 (Suppl 1): 48-54.
9. Kitzo K W, Dunkley S, Kingori M, Reid T. Lost to follow-up from tuberculosis treatment in an urban informal settlement (Kibera), Nairobi, Kenya: what are the rates and determinants? Trans R Soc Trop Med Hyg 2011; 105: 52-57.
10. Geng E H, Glidden D V, Emenyonu N, et al. Tracking a sample of patients lost to follow-up has a major impact on understanding determinants of survival in HIV-infected patients on antiretroviral therapy in Africa. Trop Med Int Health 2010; 15 (Suppl 1): 63-69.
11. Gerver S M, Chadborn T R, Ibrahim F, Vatsa B, Delpech V C, Easterbrook P J. High rate of loss to clinical follow-up among African HIV-infected patients attending a London clinic: a retrospective analysis of a clinical cohort. J Int AIDS Soc 2010; 13: 29.
12. Rosen S, Fox M P, Gill C J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systemic review. Plos Med 2007; 4: e298.
13. Obasanjo O O, Kumenda N. Factors related to attrition in a cohort study of HIV in Malawi. East Afr Med J 2009; 86: 399-408.